UK markets closed
NIKKEI 225
38,385.73 +29.67 (+0.08%) HANG SENG
19,073.71 -41.35 (-0.22%) CRUDE OIL
78.70 +0.68 (+0.87%) GOLD FUTURES
2,390.80 +30.90 (+1.31%) DOW
39,829.74 +271.63 (+0.69%) Bitcoin GBP
51,519.21 +3,101.91 (+6.41%)
IceCure Medical Ltd (ICCM)
NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
As of 02:28PM EDT. Market open.
Currency in USD
Valuation measures4
| Market cap (intra-day) | 51.22M |
| Enterprise value | 40.75M |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | 15.83 |
| Price/book (mrq) | 4.21 |
| Enterprise value/revenue | 12.62 |
| Enterprise value/EBITDA | -2.63 |
Trading information
Stock price history
| Beta (5Y monthly) | 3.00 |
| 52-week change 3 | -11.81% |
| S&P500 52-week change 3 | 26.16% |
| 52-week high 3 | 1.5700 |
| 52-week low 3 | 0.5200 |
| 50-day moving average 3 | 1.2223 |
| 200-day moving average 3 | 1.0865 |
Share statistics
| Avg vol (3-month) 3 | 486.7k |
| Avg vol (10-day) 3 | 227.87k |
| Shares outstanding 5 | 45.73M |
| Implied shares outstanding 6 | 47.36M |
| Float 8 | 18.9M |
| % held by insiders 1 | 59.30% |
| % held by institutions 1 | 0.50% |
| Shares short (30 Apr 2024) 4 | 279.23k |
| Short ratio (30 Apr 2024) 4 | 0.37 |
| Short % of float (30 Apr 2024) 4 | 1.37% |
| Short % of shares outstanding (30 Apr 2024) 4 | 0.61% |
| Shares short (prior month 28 Mar 2024) 4 | 353.56k |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | N/A |
| Last split date 3 | N/A |
Financial highlights
Fiscal year
| Fiscal year ends | 31 Dec 2023 |
| Most-recent quarter (mrq) | 31 Dec 2023 |
Profitability
| Profit margin | 0.00% |
| Operating margin (ttm) | -272.11% |
Management effectiveness
| Return on assets (ttm) | -41.78% |
| Return on equity (ttm) | -77.97% |
Income statement
| Revenue (ttm) | 3.23M |
| Revenue per share (ttm) | 0.07 |
| Quarterly revenue growth (yoy) | 33.70% |
| Gross profit (ttm) | N/A |
| EBITDA | -15.25M |
| Net income avi to common (ttm) | -14.65M |
| Diluted EPS (ttm) | -0.3200 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | 11.06M |
| Total cash per share (mrq) | 0.24 |
| Total debt (mrq) | 599k |
| Total debt/equity (mrq) | 4.93% |
| Current ratio (mrq) | 3.66 |
| Book value per share (mrq) | 0.27 |
Cash flow statement
| Operating cash flow (ttm) | -12.52M |
| Levered free cash flow (ttm) | -7.75M |
© 2024 Yahoo. All rights reserved.